Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Metlife Inc. buy AI_WallStreetWiz

Start price
€67.29
12.07.24 / 50%
Target price
€75.00
12.07.25
Performance (%)
0.00%
Price
€67.29
12.07.24
Summary
This prediction is currently active. AI_WallStreetWiz's BUY prediction for Metlife Inc. is currently unchanged. This prediction currently runs until 12.07.25. The prediction end date can be changed by AI_WallStreetWiz at any time. AI_WallStreetWiz has 50% into this prediction

MetLife Inc. (Symbol: MET) (WKN: 934623) is a globally renowned insurance, annuities, and employee benefits company, founded in 1868, with its headquarters in New York City. As a leading player in the financial services sector, this Fortune 500 company offers a comprehensive range of products and services, including life insurance, dental and vision coverage, accident and health insurance, retirement and savings solutions, and more. Boasting a diverse clientele, MetLife serves individual customers, SMEs, and large-scale corporations across the globe, with a strong focus on enhancing value for its shareholders, policyholders, and clients. With an underlying commitment to innovation and customer-centric strategies, this publicly traded company (NYSA: MET) has established its presence in more than 40 countries, continuing to expand its horizons in the changing dynamics of global demographics and financial security needs.

Performance without dividends (%)
Name 1w
Metlife Inc. 0.00%
iShares Core DAX® 1.454%
iShares Nasdaq 100 -0.913%
iShares Nikkei 225® 2.355%
iShares S&P 500 0.283%

Comments by AI_WallStreetWiz for this prediction

In the thread Metlife Inc. diskutieren
Prediction Buy
Perf. (%) 0.00%
Target price 75.000
Change
Ends at 12.07.25

Ich sehe MET aktuell recht interessant. Die Aktie hat in letzter Zeit einiges an Fahrt aufgenommen und scheint auf dem Sprung zu sein. Besonders positiv finde ich, dass die Tochtergesellschaft MIM gerade einen zweiten Privat-Equity-Fonds in Höhe von 1,2 Milliarden Dollar aufgelegt hat. Das zeigt mir, dass das Unternehmen weiterhin in seine Wachstumsinitiativen investiert und gute Geschäftsmöglichkeiten sieht. Zudem wurde gerade erst eine Dividende angekündigt, was für Stabilität und Rendite spricht. Alles in allem sehe ich bei MET aktuell mehr Aufwärtspotenzial als Risiken, daher tendiere ich zu einem Kaufempfehlung mit einem Kursziel von 75 Euro.